Volume | 931,317 |
|
|||||
News | - | ||||||
Day High | 200.155 | Low High |
|||||
Day Low | 197.01 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Laboratory Corporation of America Holdings | LH | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
197.08 | 197.01 | 200.155 | 198.40 | 198.35 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
24,272 | 931,317 | $ 198.46 | $ 184,826,983 | - | 195.01 - 243.30 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 110,270 | $ 198.40 | USD |
Laboratory Corporation o... (LH) Options Flow Summary
Laboratory Corporation of America Holdings Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.68B | 84.10M | - | 12.16B | 418M | 4.97 | 39.90 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Laboratory Corporation o... News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 200.73 | 210.63 | 196.11 | 202.58 | 1,047,692 | -2.33 | -1.16% |
1 Month | 217.29 | 217.785 | 196.11 | 205.63 | 780,779 | -18.89 | -8.69% |
3 Months | 223.01 | 229.46 | 196.11 | 213.01 | 780,065 | -24.61 | -11.04% |
6 Months | 199.48 | 234.09 | 195.01 | 215.06 | 770,321 | -1.08 | -0.54% |
1 Year | 220.14 | 243.30 | 195.01 | 214.20 | 748,043 | -21.74 | -9.88% |
3 Years | 264.99 | 317.17 | 195.01 | 243.39 | 727,516 | -66.59 | -25.13% |
5 Years | 154.89 | 317.17 | 98.02 | 217.68 | 740,575 | 43.51 | 28.09% |
Laboratory Corporation o... Description
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market. |